VisionSense is a pioneering company in the field of minimally invasive surgery (MIS) visualization solutions, offering unparalleled depth perception and surgical precision. Founded in 1998, the company utilizes advanced sensor technology and proprietary software to provide natural stereoscopic sight, 3D-HD resolution images, and flexible maneuvering through minimal access points, revolutionizing the current 2D (monocular) imaging standard for MIS. The stereovision capabilities not only enhance tissue understanding and hand-eye coordination but also increase surgeons' confidence in utilizing advanced surgical tools.
Having recently secured an $8.00M Venture Round investment on 01 April 2018, VisionSense's notable investors include Star Ventures, Volcano Capital, Wheatley Partners, GlenRock Israel, TechnoPlus Ventures, and Shalom Equity Fund. The company operates in the VR/AR and Autonomous and Sensor Tech industries, positioning itself at the cutting edge of technological innovation in healthcare and visualization. With its focus on advanced minimally invasive procedures, VisionSense holds significant potential for growth and impact in the healthcare sector.
OnLume